CN103041011B - Oral drug for treating gosling candidiasis - Google Patents
Oral drug for treating gosling candidiasis Download PDFInfo
- Publication number
- CN103041011B CN103041011B CN201310029151.5A CN201310029151A CN103041011B CN 103041011 B CN103041011 B CN 103041011B CN 201310029151 A CN201310029151 A CN 201310029151A CN 103041011 B CN103041011 B CN 103041011B
- Authority
- CN
- China
- Prior art keywords
- parts
- candidiasis
- goose
- medicine
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000222122 Candida albicans Species 0.000 title claims abstract description 33
- 206010007134 Candida infections Diseases 0.000 title claims abstract description 32
- 201000003984 candidiasis Diseases 0.000 title claims abstract description 32
- 229940126701 oral medication Drugs 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 46
- 241000272814 Anser sp. Species 0.000 claims abstract description 27
- 229960000988 nystatin Drugs 0.000 claims abstract description 21
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 claims abstract description 21
- 235000021419 vinegar Nutrition 0.000 claims abstract description 17
- 239000000052 vinegar Substances 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000606264 Patrinia Species 0.000 claims abstract description 13
- 235000019109 Patrinia villosa Nutrition 0.000 claims abstract description 13
- 239000010075 Qingdai compound Substances 0.000 claims abstract description 13
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 13
- 229940116229 borneol Drugs 0.000 claims abstract description 13
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims description 7
- 239000007900 aqueous suspension Substances 0.000 claims description 5
- 210000000214 mouth Anatomy 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 208000025157 Oral disease Diseases 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000000857 drug effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 7
- 239000002674 ointment Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- YADZBEISHVCBSJ-UHFFFAOYSA-N [I].OCC(O)CO Chemical compound [I].OCC(O)CO YADZBEISHVCBSJ-UHFFFAOYSA-N 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000002200 mouth mucosa Anatomy 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 208000007027 Oral Candidiasis Diseases 0.000 description 3
- 208000007117 Oral Ulcer Diseases 0.000 description 3
- 241000287411 Turdidae Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 241000272808 Anser Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010067993 Mucosal necrosis Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035039 Piloerection Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039740 Screaming Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗雏鹅白色念珠菌病的口腔用药物及其制备方法。它的重量组份为:白鲜皮15-25份、败酱草12-18份、黄柏12-18份、苦参12-18份、青黛8-12份、制霉菌素6-8份、冰片2-4份、陈醋50-70份。上述药物经有机组合,辩证配伍和相互辅佐,增强了该方清热燥湿,解毒散瘀的功效,从而达到治愈雏鹅白色念珠菌病口腔病变的目的。特别是将药物直接投向患鹅口腔病灶,从而直接发挥药效。采用本发明一种治疗雏鹅白色念珠菌病的口腔用药物的制备方法制得的雏鹅白色念珠菌病的口腔用药物具有成本低、制备容易,无毒副作用、且疗效显著。临床实践证明,该药的治愈率96.68%,有效率100%。The invention provides an oral medicine for treating goose candidiasis and a preparation method thereof. Its weight components are: 15-25 parts of white fresh skin, 12-18 parts of Patrinia, 12-18 parts of Cortex Phellodendri, 12-18 parts of Sophora flavescens, 8-12 parts of Qingdai, 6-8 parts of nystatin, 2-4 parts of borneol, 50-70 parts of mature vinegar. The organic combination, dialectical compatibility and mutual assistance of the above-mentioned medicines enhance the efficacy of the prescription for clearing away heat and dampness, detoxifying and dispelling blood stasis, so as to achieve the purpose of curing oral lesions of goose candidiasis albicans. In particular, the medicine is directly injected into the oral lesions of the suffering goose, so as to directly exert the drug effect. The oral medicine for goose candidiasis prepared by the preparation method of the oral medicine for treating goose candidiasis has the advantages of low cost, easy preparation, no toxic and side effects, and remarkable curative effect. Clinical practice has proved that the drug has a cure rate of 96.68% and an effective rate of 100%.
Description
技术领域 technical field
本发明涉及一种治疗雏鹅白色念珠菌病的口腔用药物及其制备方法。 The invention relates to an oral medicine for treating goose candidiasis and a preparation method thereof. the
背景技术 Background technique
雏鹅白色念珠菌病又称鹅口疮,是由白色念珠菌引起的一种禽类上消化道真菌性传染病,特征是在口腔、咽喉等上消化道黏膜上形成乳白色斑片(假膜)并导致黏膜发炎,引起溃疡或鳞屑状病变。该菌广泛存在于自然界及健康禽的消化道、呼吸道中。当各种原因使机体抵抗力下降时,如不良的环境条件、维生素缺乏及长期使用抗菌素等,使消化道菌群平衡失调而诱发本病。本病禽类易感,鹅以6 周龄以内的雏鹅易感性高。本病主要经消化道传播,污染的饲料、饮水、垫料等都是传播媒介;同时也可经蛋壳传播。本病传播迅速,发病率与死亡率均高,给养殖户带来很大经济损失。 Gosling candidiasis albicans, also known as thrush, is a fungal infectious disease of the upper gastrointestinal tract of poultry caused by Candida albicans, characterized by the formation of milky white patches (pseudomembranes) on the upper gastrointestinal mucosa of the mouth, throat, etc. Causes inflammation of the mucous membranes, causing ulcers or scaly lesions. The bacterium widely exists in nature and in the digestive tract and respiratory tract of healthy poultry. When various reasons reduce the body's resistance, such as poor environmental conditions, vitamin deficiency and long-term use of antibiotics, the balance of the digestive tract flora is imbalanced and the disease is induced. Poultry are susceptible to this disease, and geese are highly susceptible to goslings within 6 weeks of age. The disease is mainly transmitted through the digestive tract, and contaminated feed, drinking water, bedding, etc. are all transmission media; it can also be transmitted through eggshells. The disease spreads rapidly, and the morbidity and mortality are high, which brings great economic losses to farmers. the
临床症状及病理变化 Clinical symptoms and pathological changes
多发生于6 周龄以内的雏鹅,患鹅精神萎靡,羽毛松乱,生长缓慢,呆立,食欲减少或废绝,嗉嚷扩张、下垂、松软,压迫有疼痛感(鸣叫和挣扎)。将病鹅倒提常有大量带酸败气味的液体从口鼻腔流出。在口腔粘膜及舌面上出现乳白色或黄色斑点,后融合成白膜。有干酪样的典型鹅口疮,用力剥离后可见红色的出血性溃疡面,患病雏鹅最后消瘦而死亡。病理剖检,口腔病变外,干酪样坏死性假膜多见于嗉嚷,粘膜增厚,形成白色豆粒大小结节和溃疡,其上覆盖一层白色假膜。在食道和腺胃等处也能见到上述病变。刮下嗉囊黏膜坏死物制涂片,染色后镜检,可发现酵母样真菌。 It mostly occurs in goslings less than 6 weeks old. The affected geese are depressed, with loose feathers, slow growth, standing still, loss of appetite or loss of appetite, dilated, drooping, soft, and oppressive pain (screaming and struggling). When the sick goose is lifted upside down, a large amount of rancid smelling liquid often flows out of the mouth and nose. Milky white or yellow spots appear on the oral mucosa and tongue, and then merge into a white film. There are typical thrush like cheese, and the red bleeding ulcer surface can be seen after peeling off forcefully. The sick gosling finally becomes emaciated and dies. Pathological autopsy shows that, except for oral lesions, caseous necrotic pseudomembrane is more common in crops, and the mucosa thickens, forming white bean-sized nodules and ulcers, which are covered with a layer of white pseudomembrane. The above-mentioned lesions can also be seen in the esophagus and glandular stomach. Scraping the crop mucosal necrosis to make a smear, microscopic examination after staining, yeast-like fungi can be found.
目前防治措施 Current prevention and control measures
对于该病的治疗,临床上没有较好的治疗药物,西药疗效较差,且有依赖性强,副作用较大,易反复等不足。而常用的口腔局部用药物,如碘甘油等药物应用后效果不显著,常至患鹅疼痛加剧影响进食。 For the treatment of this disease, there is no good therapeutic drug clinically, and the curative effect of western medicine is poor, and it has strong dependence, large side effects, and easy recurrence. However, the commonly used local oral medicines, such as iodine glycerin, have no significant effect after application, and often the pain of suffering from goose aggravates and affects eating.
为克服上述不足,本发明的目的是要提供一种治疗雏鹅白色念珠菌病的口腔用药物及其制备方法,该药物以局部治疗为主能有效的减轻疼痛症状、促进愈合,不反复,并且无任何副作用。 In order to overcome the above-mentioned shortcomings, the purpose of the present invention is to provide a kind of oral medicine for the treatment of gosling candidiasis and its preparation method. And without any side effects. the
发明内容: Invention content :
本发明的目的在于克服目前在治疗雏鹅白色念珠菌病上的不足之处,提供一种取材容易、制备方便、减少药物残留及毒副作用,且价格低廉疗效较高的治疗雏鹅白色念珠菌病的口腔用药物。 The purpose of the present invention is to overcome the current shortcomings in the treatment of candidiasis in gooses, and provide a treatment for candida albicans in gooses that is easy to obtain, convenient to prepare, reduces drug residues and side effects, and is low in price and high in curative effect. Oral medicines for sickness.
一种治疗雏鹅白色念珠菌病的口腔用药物,它的重量组份为:白鲜皮15-25份、败酱草12-18份、黄柏12-18份、苦参12-18份、青黛8-12份、100万单位/克制霉菌素6-8份、冰片2-4份、陈醋50-70份。 An oral medicament for treating goose candidiasis, the components by weight are: 15-25 parts of white fresh skin, 12-18 parts of Patrinia, 12-18 parts of Cortex Phellodendri, 12-18 parts of Sophora flavescens, 8-12 parts of Qingdai, 6-8 parts of 1 million units/grammycin, 2-4 parts of borneol, 50-70 parts of mature vinegar. the
优选的重量组份为: Preferred weight components are:
白鲜皮25份、败酱草12份、黄柏18份、苦参12份、青黛12份、制霉菌素6份、冰片2份、陈醋70份。 25 parts of white fresh skin, 12 parts of Patrinia, 18 parts of Cortex Phellodendri, 12 parts of Sophora flavescens, 12 parts of Qingdai, 6 parts of nystatin, 2 parts of borneol, 70 parts of mature vinegar.
或为: or as:
白鲜皮15份、败酱草18份、黄柏12份、苦参18份、青黛8份、制霉菌素8份、冰片4份、陈醋50份。 15 parts of white fresh skin, 18 parts of Patrinia, 12 parts of Cortex Phellodendri, 18 parts of Sophora flavescens, 8 parts of Qingdai, 8 parts of nystatin, 4 parts of borneol, 50 parts of mature vinegar.
或为: or as:
白鲜皮20份、败酱草15份、黄柏15份、苦参15份、青黛10份、制霉菌素7份、冰片3份、陈醋60份。 20 parts of white fresh skin, 15 parts of Patrinia, 15 parts of Cortex Phellodendri, 15 parts of Sophora flavescens, 10 parts of Qingdai, 7 parts of nystatin, 3 parts of borneol, 60 parts of mature vinegar.
本发明的又一个目的是提供一种治疗雏鹅白色念珠菌病的口腔用药物,是由下述方法制备: Another object of the present invention is to provide a kind of oral medicine for the treatment of gosling candidiasis, which is prepared by the following method:
按一种治疗雏鹅白色念珠菌病的口腔用药物的原料配比称取各组份,将其中的中药粉碎后,过120目筛后,将制霉菌素片碾成粉末加入生理盐水, 制备成5 万~ 10 万U / ml 的水混悬液,和其他药物混合,并加入陈醋,加的过程中不断的搅拌,使其药物混合均匀,充分溶解成为膏剂,既得治疗雏鹅白色念珠菌病的口腔用中药组合物膏剂。 Weigh each component according to the raw material ratio of a oral medicine for the treatment of goose candidiasis albicans, crush the traditional Chinese medicine in it, pass through a 120-mesh sieve, grind nystatin tablets into powder and add physiological saline to prepare Make an aqueous suspension of 50,000 to 100,000 U/ml, mix it with other medicines, add mature vinegar, and stir continuously during the addition process to make the medicines mix evenly and fully dissolve into ointment, which can treat Candida albicans in goslings Sick oral cavity with traditional Chinese medicine composition ointment.
一种治疗雏鹅白色念珠菌病的口腔用药物,方中: A kind of oral medicine for the treatment of gosling candidiasis albicans, in the prescription:
白鲜皮:苦;咸;寒。归脾、肺、小肠、胃、膀胱经。具有清热燥湿;祛风止痒;解毒之功。主治:风热湿毒所致的风疹;湿疹;疥癣;黄疸;湿热痹。体外试验表明,对真菌有不同程度的抑制作用,特别是对白色念珠菌病有较好的治疗作用,且有强心及清热等功效。 Radix Cortex: bitter; salty; cold. Return spleen, lung, small intestine, stomach, urinary bladder channel. Have heat-clearing and damp-drying; Expelling wind and relieving itching; The merit of detoxification. Indications: rubella caused by wind-heat-damp poisoning; eczema; scabies; jaundice; damp-heat arthralgia. In vitro tests have shown that it has different degrees of inhibitory effects on fungi, especially has a good therapeutic effect on candidiasis albicans, and has the effects of strengthening the heart and clearing away heat.
败酱草:辛、苦,微寒。归胃、大肠、肝经。具有清热解毒,消痈排脓,祛瘀止痛之功。 本品辛散苦泄寒凉,既可清热解毒,又可消痈排脓,且能活血止痛,故为治疗肠痈腹痛的首选药物。对多种病原菌及病毒有抑制作用。常用于多种急性感染性疾病,也可水煎熏洗,或以鲜品捣烂外敷,特别对于治疗鹅口疮等疾患可获满意疗效。也可治疗毛囊炎、疖等化脓性皮肤病。 Patrinia: pungent, bitter, slightly cold. Return stomach, large intestine, Liver Channel. Have heat-clearing and toxic substances removing, eliminate carbuncle and expel pus, remove blood stasis and relieve pain. This product is pungent and bitter, expels cold and cool, can clear heat and detoxify, eliminate carbuncle and expel pus, and can activate blood and relieve pain, so it is the first choice drug for treating intestinal carbuncle and abdominal pain. It has inhibitory effect on a variety of pathogenic bacteria and viruses. It is commonly used in various acute infectious diseases. It can also be decocted and fumigated, or fresh products can be mashed and applied externally, especially for the treatment of thrush and other diseases to obtain satisfactory curative effect. It can also treat purulent skin diseases such as folliculitis and boils.
黄柏:苦、寒。归肾、膀胱、大肠经。具有清热燥湿,泻火解毒,退虚热之功,体外试验对多种病原菌均有较强的抑制作用,特别是有较强的抗真菌作用,尤其对白色念珠菌的抑制作用较强。对于治疮痈,湿疹,湿疮有较好的治疗效果,尤其对口舌生疮;目赤肿痛;痈疽疮毒,等疾病疗效显著。且有抗溃疡、利尿、健胃、外用等作用。 苦参:苦、寒。入心、肝、胃、大肠、膀胱经。具有清热燥湿,祛风杀虫及利尿之功,对于湿热所致的黄疸、泻痢有很好的疗效,对于肺风毛躁等皮肤瘙痒症、一些真菌性皮肤病、湿毒疮疡、口疮等都有较好的治疗作用。 青黛:咸,寒。归肝经。具有清热解毒,凉血之功。可用于温毒发斑、口疮、痄腮等疾病,对于鹅念珠菌性口疮有较好的治疗效果。 Cortex Phellodendri: bitter, cold. Return kidney, bladder, large intestine channel. It has the functions of clearing away heat and dampness, purging fire and detoxification, and reducing asthenic fever. In vitro tests have strong inhibitory effects on various pathogenic bacteria, especially strong antifungal effects, especially strong inhibitory effects on Candida albicans. It has a good therapeutic effect on treating sores and carbuncles, eczema, and eczema, especially for sores on the mouth and tongue; red eyes and swelling; carbuncles and sores, and other diseases. And there are anti-ulcer, diuretic, stomach invigorating, external use and other effects. Sophora flavescens: bitter, cold. Go into the heart, liver, stomach, large intestine, urinary bladder channel. It has the functions of clearing away heat and dampness, expelling wind, killing insects and diuresis. It has a good curative effect on jaundice and diarrhea caused by damp heat. etc. have a better therapeutic effect. Qingdai: salty, cold. Return liver channel. Have heat-clearing and toxic substances removing, the merit of cooling blood. It can be used for diseases such as febrile plaques, aphthous sores, mumps, etc. It has a good therapeutic effect on Candida goosebumps.
冰片:辛、苦、微寒。入心、肝、脾、肺经。具有通诸窍,散郁火,去翳明目,消肿止痛之功,主要用治热病神昏、喉痹、口疮、痈肿等症。本品苦寒,有清热止痛、消肿之功,为五官科常用药,外用有较强的抑菌作用,粘膜、皮下组织均易吸收,常用于咽喉肿痛、口舌生疮等症。 Borneol: pungent, bitter, slightly cold. Go into the heart, liver, spleen, lung meridian. It has the functions of clearing the orifices, dispersing stagnant fire, removing cloudiness and improving eyesight, reducing swelling and relieving pain, and is mainly used to treat febrile diseases, coma, sore throat, aphtha, carbuncle and other diseases. This product is bitter and cold, has the function of clearing away heat, relieving pain and reducing swelling.
陈醋:酸,温。入肝、胃经。具有散瘀、止血、解毒、杀虫的功效,有良好的抑菌和杀菌作用,能有效的预防一些传染病,可软化血管,降低胆固醇,外用对皮肤也有很好的保护作用,多用于一些痈疽疮肿的治疗,对于真菌感染也有很好的治疗作用。 Mature vinegar: sour, warm. Go into liver, stomach warp. It has the effects of dispelling blood stasis, hemostasis, detoxification, and killing insects. It has good antibacterial and bactericidal effects. It can effectively prevent some infectious diseases, soften blood vessels, and lower cholesterol. It also has a good protective effect on the skin when used externally. It is mostly used in some The treatment of carbuncle sores also has a good therapeutic effect on fungal infections.
制霉菌素:多烯类抗真菌药,具广谱抗真菌作用,对念珠菌属的抗菌活性高。 本品可与真菌细胞膜上的甾醇相结合,致细胞膜通透性的改变,以致重要细胞内容物漏失而发挥抗真菌作用。 Nystatin: Polyene antifungal drug with broad-spectrum antifungal effect and high antibacterial activity against Candida. This product can be combined with sterols on the fungal cell membrane, resulting in a change in the permeability of the cell membrane, resulting in the loss of important cell contents and exerting an antifungal effect.
上述药物经有机组合,辩证配伍和相互辅佐,增强了该方清热燥湿,解毒散瘀的功效,从而达到治愈雏鹅白色念珠菌病口腔病变的目的。特别是将药物直接投向患鹅口腔病灶,从而直接发挥药效。采用本发明一种治疗雏鹅白色念珠菌病的口腔用药物的制备方法制得的雏鹅白色念珠菌病的口腔用药物具有成本低、制备容易,无毒副作用、且疗效显著。临床实践证明,该药的治愈率96.68%,有效率100%。 The organic combination, dialectical compatibility and mutual assistance of the above-mentioned medicines enhance the efficacy of the prescription for clearing away heat and dampness, detoxifying and dispelling blood stasis, so as to achieve the purpose of curing oral lesions of goose candidiasis albicans. In particular, the medicine is directly injected into the oral lesions of the suffering goose, so as to directly exert the drug effect. The oral medicine for goose candidiasis prepared by the preparation method of the oral medicine for treating goose candidiasis has the advantages of low cost, easy preparation, no toxic and side effects, and remarkable curative effect. Clinical practice has proved that the drug has a cure rate of 96.68% and an effective rate of 100%. the
具体实施方式 Detailed ways
实施例1Example 1
白鲜皮25份、败酱草12份、黄柏18份、苦参12份、青黛12份、制霉菌素6份、冰片2份、陈醋70份。 25 parts of white fresh skin, 12 parts of Patrinia, 18 parts of Cortex Phellodendri, 12 parts of Sophora flavescens, 12 parts of Qingdai, 6 parts of nystatin, 2 parts of borneol, 70 parts of mature vinegar.
或为: or as:
实施例2Example 2
白鲜皮15份、败酱草18份、黄柏12份、苦参18份、青黛8份、制霉菌素8份、冰片4份、陈醋50份。 15 parts of white fresh skin, 18 parts of Patrinia, 12 parts of Cortex Phellodendri, 18 parts of Sophora flavescens, 8 parts of Qingdai, 8 parts of nystatin, 4 parts of borneol, 50 parts of mature vinegar.
实施例3Example 3
重量组份:白鲜皮20份、败酱草15份、黄柏15份、苦参15份、青黛10份、制霉菌素7份、冰片3份、陈醋60份。 Components by weight: 20 parts of white fresh skin, 15 parts of Patrinia, 15 parts of Cortex Phellodendri, 15 parts of Sophora flavescens, 10 parts of Qingdai, 7 parts of nystatin, 3 parts of borneol, 60 parts of mature vinegar.
实施例4Example 4
按实施例1、2或3配比称重,将其中的中药粉碎成细粉后,过120目筛后备用,将制霉菌素片碾成粉末加入生理盐水, 制备成5 万~ 10 万U / ml 的水混悬液,和粉碎后备用的中药混合,并加入陈醋,加的过程中不断的搅拌,使其药物混合均匀,充分溶解成为膏剂,既得治疗雏鹅白色念珠菌病的口腔用中药组合物膏剂。 Weigh according to the ratio of Example 1, 2 or 3, crush the Chinese medicine into fine powder, pass through a 120-mesh sieve for later use, grind nystatin tablets into powder and add physiological saline to prepare 50,000-100,000 U / ml of water suspension, mixed with crushed traditional Chinese medicine, and added mature vinegar, stirring continuously during the addition process, so that the medicine is mixed evenly, fully dissolved into ointment, and it can be used for oral treatment of goose candidiasis albicans Traditional Chinese medicine composition ointment.
临床疗效试验Clinical Efficacy Trial
1.方法:选发生雏鹅白色念珠菌病的养殖场两家,共挑选有口腔病变的雏鹅1287只雏鹅,年龄为3-4周龄。将发病雏鹅分为三组,分别为本发明组、制霉菌素组及碘甘油组。 1. Method: Two farms where gosling albicans occurred were selected, and a total of 1287 goslings with oral lesions were selected, aged 3-4 weeks. The diseased goslings were divided into three groups, namely the present invention group, nystatin group and iodine glycerol group.
本发明组按实施例3配比称重,将其中的中药粉碎成细粉后,过120目筛后备用,将制霉菌素片碾成粉末加入生理盐水, 制备成5 万~ 10 万U / ml 的水混悬液,和粉碎后备用的中药混合,并加入陈醋,加的过程中不断的搅拌,使其药物混合均匀,充分溶解成为膏剂,既得治疗雏鹅白色念珠菌病的口腔用中药组合物膏剂。直接用棉球蘸取药液涂抹患鹅口腔溃疡面。 The group of the present invention is weighed according to the proportion of Example 3, after crushing the traditional Chinese medicine into fine powder, passing through a 120-mesh sieve for later use, grinding nystatin tablets into powder and adding physiological saline to prepare 50,000-100,000 U/s ml of water suspension, mixed with crushed traditional Chinese medicine, and added mature vinegar, stirring continuously during the addition process, so that the medicine is mixed evenly, fully dissolved into ointment, and the oral traditional Chinese medicine for the treatment of goose candidiasis albicans Composition ointment. Directly use a cotton ball dipped in the liquid to smear the surface of the affected goose with oral ulcers. the
制霉菌素组是将制霉菌素片碾成粉末加入生理盐水, 制备成5 万~ 10 万U / ml 的水混悬液,直接用棉球蘸取药液涂抹患鹅口腔溃疡面。 In the nystatin group, nystatin tablets were ground into powder and added to normal saline to prepare an aqueous suspension of 50,000 to 100,000 U/ml, and the cotton ball was directly dipped in the liquid to smear the surface of the affected goose with oral ulcers. the
碘甘油购自长春吉林大药房,由上海运佳黄埔制药有限公司生产,每毫升含主要成分碘10毫克,直接用棉球蘸取药液涂抹患鹅口腔溃疡面。 Iodine glycerin was purchased from Changchun Jilin Pharmacy and produced by Shanghai Yunjia Huangpu Pharmaceutical Co., Ltd. It contained 10 mg of iodine as the main component per milliliter, and was directly dipped in a cotton ball to take the liquid and smeared on the surface of the affected goose with oral ulcers. the
治疗时间为5天,每天上、下午各涂药一次。 The treatment time is 5 days, and the medicine is applied once in the morning and afternoon every day. the
表1 雏鹅分组及主要治疗方法 Table 1 Grouping of goslings and main treatment methods
---------------------- ----------------------
各组病例在口腔局部用药的同时,采用同样的整体治疗方法,饲料中添加制霉菌素,药物由济南佳德新兽药原料有限公司生产,按每公斤饲料加入100万单位的剂量拌入,连用五天。 The cases in each group adopted the same overall treatment method while local oral medication was used. Nystatin was added to the feed. The drug was produced by Jinan Jiade New Veterinary Drug Raw Materials Co., Ltd. and mixed in at a dose of 1 million units per kilogram of feed. sky.
2.疗效判定: 2. Judgment of curative effect:
治愈:雏鹅白色念珠菌病症状及口腔粘膜及舌面上溃疡面完全消失。 Cure: gosling candidiasis albicans symptom and ulcer surface on oral mucosa and tongue surface disappear completely.
好转: 雏鹅白色念珠菌病症状及口腔粘膜及舌面上溃疡面部分消失。 Improvement: The symptoms of candidiasis albicans and part of the oral mucosa and tongue ulcers disappeared. the
无效: 雏鹅白色念珠菌病症状及口腔粘膜及舌面上溃疡面没有变化。 Ineffective: The symptoms of candidiasis albicans in goslings and ulcers on the oral mucosa and tongue remained unchanged. the
3.结果:1287只雏鹅通过不同的给药方案,经过三天的治疗后,各组的治疗效果见表2。 3. Results: 1287 goslings were treated with different dosing regimens. After three days of treatment, the treatment effects of each group are shown in Table 2. the
表2 各种治疗方案治疗雏鹅效果 Table 2 The effect of various treatment schemes on goslings
由表2 可见, 三种药物对雏鹅念珠菌病有不同的治疗效果, 其中以本发明组治疗效果最好, 治愈率达96.68%,总有效率100% , 极显著高于其它两组(P < 0. 01); 制霉菌素组次之, 碘甘油组再次,统计学结果表明, 各组间差异显著( P< 0. 05) 。 It can be seen from Table 2 that the three drugs have different therapeutic effects on goose candidiasis, among which the group of the present invention has the best therapeutic effect, with a cure rate of 96.68% and a total effective rate of 100%, which is significantly higher than that of the other two groups ( P < 0. 01); followed by the nystatin group, followed by the iodine glycerin group, and the statistical results showed that there were significant differences among the groups ( P < 0. 05) .
多年来,采用实施例1、2、3的配比,按实施例4方法制备的药物,经多家发生雏鹅念珠菌病的养殖场的雏鹅进行治疗,治愈率均在96左右,总有效率均达100%。本发明药物具有祛腐生肌、止痛、收湿、消炎杀菌,修复溃疡面的作用,减轻疼痛症状、促进愈合,并且无任何副作用。对于雏鹅白色念珠菌病的口腔病变具有较好的疗效。为临床治疗该病提供了一种切实可行的新药。 For many years, adopt the proportioning of embodiment 1,2,3, the medicine prepared by the method of embodiment 4, treat the goslings of the breeding farm that takes place gosling candidiasis through many goslings, and cure rate is all about 96, and total The effective rates are all up to 100%. The medicine of the invention has the functions of removing putrefaction and promoting granulation, relieving pain, removing dampness, reducing inflammation and sterilizing, repairing ulcer surface, alleviating pain symptoms, promoting healing, and without any side effect. It has a good curative effect on the oral lesions of goose candidiasis albicans. A practical new drug is provided for the clinical treatment of the disease. the
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310029151.5A CN103041011B (en) | 2013-01-25 | 2013-01-25 | Oral drug for treating gosling candidiasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310029151.5A CN103041011B (en) | 2013-01-25 | 2013-01-25 | Oral drug for treating gosling candidiasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041011A CN103041011A (en) | 2013-04-17 |
| CN103041011B true CN103041011B (en) | 2014-06-04 |
Family
ID=48054022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310029151.5A Expired - Fee Related CN103041011B (en) | 2013-01-25 | 2013-01-25 | Oral drug for treating gosling candidiasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041011B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107334781A (en) * | 2016-05-02 | 2017-11-10 | 南昌市第九医院 | A kind of medicine for being used to prevent and treat buccal cavity fungal infection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732403A (en) * | 2010-01-26 | 2010-06-16 | 王斐芬 | Chinese medicament for treating muguet |
-
2013
- 2013-01-25 CN CN201310029151.5A patent/CN103041011B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107334781A (en) * | 2016-05-02 | 2017-11-10 | 南昌市第九医院 | A kind of medicine for being used to prevent and treat buccal cavity fungal infection |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041011A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102640876A (en) | Feed and injection used for treating duck virus hepatitis and preparation method of feed and injection | |
| CN104524506B (en) | A kind of clean filling agent in Chinese medicine palace for the treatment of endometritis of livestock and preparation method thereof | |
| CN103041011B (en) | Oral drug for treating gosling candidiasis | |
| CN103239667B (en) | Chinese traditional medicine for treating foot-and-mouth disease of domestic animals | |
| CN106690121A (en) | Trepang, hippophae rhamnoides fruit, cordyceps militaris and selenium preparation and preparation technology thereof | |
| CN103301385A (en) | Traditional Chinese medicine composition for treating animal diarrhea and preparation method thereof | |
| CN102526639A (en) | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof | |
| CN107397886A (en) | Chinese medicine composition for preventing and treating piglet red dysentery and its preparation method and application | |
| CN111773341A (en) | A compound Chinese herbal medicine external preparation for treating scabies of piglets | |
| CN104758358A (en) | A kind of pharmaceutical composition for eczema and preparation method thereof | |
| CN104606627B (en) | A kind of pharmaceutical composition for treating grice diarrhoea and preparation method thereof | |
| CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
| CN105412815B (en) | Traditional Chinese medicine composition for treating hyperthyroidism | |
| CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
| CN101912449B (en) | Medicament for treating hepatitis and preparation technology thereof | |
| CN102579829B (en) | Traditional Chinese medicine composition for treating bovine actinomycosis and preparation method of same | |
| CN109939211A (en) | Chinese veterinary medicinal preparation for treating chicken colibacillosis and preparation method thereof | |
| CN107519269A (en) | A kind of de- mould detoxification Chinese traditional medicine powder for animals and preparation method thereof | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN102988534A (en) | External medicine for treating burns and scalds and preparation method thereof | |
| CN108126114B (en) | A kind of Chinese medicine sustained-release microparticle medicated meal for detoxification and detoxification and preparation method thereof | |
| CN106361902A (en) | Traditional Chinese medicine composition for preventing and treating livestock diarrhea and preparation method thereof | |
| CN106359659A (en) | Composite nutrient blend oil with ulcer restoration effect, and preparation method and application thereof | |
| CN103071026B (en) | Animal traditional Chinese medicine for treating high fever and preparation method of injection solution thereof | |
| CN105125926A (en) | Medical powder for treating burns and scalds and preparation method of medical powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wen Wei Inventor after: Wang Dan Inventor after: Gao Guang Inventor after: Feng Yuanchun Inventor after: Sui Yujian Inventor after: Zhou Pin Inventor after: Hu Dan Inventor after: Sun Yongfeng Inventor after: Zhao Lifeng Inventor after: Yang Xiaojie Inventor before: Wen Wei |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WEN WEI TO: WEN WEI GAO GUANG FENG YUANCHUN SUI YUJIAN ZHOU PIN HU DAN SUNYONGFENG ZHAO LIFENG YANG XIAOJIE WANG DAN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140604 Termination date: 20150125 |
|
| EXPY | Termination of patent right or utility model |

